Docetaxel and alpha-lipoic acid co-loaded nanoparticles for cancer therapy
No Thumbnail Available
Date
2019-04
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Future Science Group
Abstract
The current study aims to co-deliver docetaxel (DTX) and alpha-lipoic acid (ALA) using solid lipid nanoparticles (SLNs) as a carrier for the treatment of breast cancer. Methods: Computational analysis was used to screen different solid lipids as carriers, following which SLNs were prepared and characterized. Furthermore, antioxidant activity assays and cell culture studies were performed. Results:In vitro assessment in 4T1 (murine mammary carcinoma) and MCF-7 (human breast adenocarcinoma) cells revealed enhanced efficacy of the co-loaded SLNs as compared with free drugs and single drug-loaded SLNs. Increased apoptosis following treatment with DTX-ALA co-loaded SLN was also observed
Description
Keywords
Pharmacy, Breast cancer, Solid lipid nanoparticles (SLNs), Cellular uptake